Qimono the complete closed system for safe delivery of cytotoxic drugs
Stay safe with Qimono
It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .
Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .
Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.
Description of the device
Spike for bags of intravenous solutions
Code 7218.01: spike with Qimo Female, for aspirating or adding fluids to bags of intravenous solutions. It can also be used with paediatric bags. The spike perforates the infusion bag while Qimo female maintains at all times a closed system allowing to aspirate or add fluids in an aseptic manner.
Code 7218.11: spike with Qimo Female and non-return valve. This spike is designed for aspiration only of fluid from I.V. bags, but no fluid can be added into the bag. It thus avoids the contamination of the I.V. fluid by drugs.
Qimo Female is a multi-purpose, closed, needle-free, small size I.V. connection device. See the corresponding technical file code 7210.02.
